Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research from the Paris International Cognition and Cancer Task Force Symposium and Update since 2012

Journal of Pain and Symptom Management

Volumn 50, Issue 6, 2015, Pages 830-841

  Joly, Florence ^a,b,c   Giffard, Bénédicte ^d,e,f,g   Rigal, Olivier ^h   De Ruiter, Michiel B ^i,j   Small, Brent J ^j   Dubois, Martine ^k   Lefel, Johan ^h   Schagen, Sanne B ⁱ   Ahles, Tim A ^l   Wefel, Jeffrey S ^m   Vardy, Janette L ⁿ   Pancré, Véronique ^o   Lange, Marie ^a,c   Castel, Hélène ^k  

^a CENTRE FRANÇOIS BACLESSE   (France)

^b CHU CÔTE DE NACRE   (France)

^c Biology and Innovative Therapeutics for Ovarian Cancers Group   (France)

^d UNIVERSITÉ DE CAEN   (France)

^e Centre Cyceron   (France)

^f PSL RESEARCH UNIVERSITY   (France)

^g CAEN UNIVERSITY HOSPITAL   (France)

^h CENTRE HENRI BECQUEREL   (France)

ⁱ ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k Université de Rouen   (France)

^l WEILL CORNELL MEDICAL COLLEGE   (United States)

^m UNIVERSITY OF TEXAS   (United States)

ⁿ UNIVERSITY OF SYDNEY   (Australia)

^o INSTITUT DE BIOLOGIE DE LILLE   (France)

more..

Author keywords

Cancer; chemotherapy; cognition; elderly; neuroimaging

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BRAIN FUNCTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RESEARCH; CANCER SURVIVOR; COGNITION; COGNITIVE DEFECT; COGNITIVE REHABILITATION; COLORECTAL CANCER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MALIGNANT NEOPLASTIC DISEASE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; PROSTATE CANCER; TESTIS CANCER; TRANSLATIONAL RESEARCH; ANIMAL; COGNITION DISORDERS; DIAGNOSTIC IMAGING; NEOPLASMS; PSYCHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; COGNITION; COGNITION DISORDERS; HUMANS; NEOPLASMS;

EID: 84948654020     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2015.06.019     Document Type: Review

References (105)

1. J.S. Wefel, S.R. Kesler, K.R. Noll, and S.B. Schagen Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults CA Cancer J Clin 65 2015 123 138
2. H.S. Jim, K.M. Phillips, S. Chait, and et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy J Clin Oncol 30 2012 3578 3587
3. K. Agrawal, S. Onami, J.E. Mortimer, and S.K. Pal Cognitive changes associated with endocrine therapy for breast cancer Maturitas 67 2010 209 214
4. C.J. Nelson, J.S. Lee, M.C. Gamboa, and A.J. Roth Cognitive effects of hormone therapy in men with prostate cancer: a review Cancer 113 2008 1097 1106
5. I.F. Tannock, T.A. Ahles, P.A. Ganz, and F.S. van Dam Cognitive impairment associated with chemotherapy for cancer: report of a workshop J Clin Oncol 22 2004 2233 2239
6. J. Vardy, S. Rourke, and I.F. Tannock Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research J Clin Oncol 25 2007 2455 2463
7. J.S. Wefel, J. Vardy, T. Ahles, and S.B. Schagen International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer Lancet Oncol 12 2011 703 708
8. J.J. McArdle, and J.R. Nesselroade Longitudinal data analysis using structural equation modeling 2014 American Psychological Association Washington, DC
9. J.D. Singer, and J.B. Willett Applied longitudinal data analysis: Modeling change and event occurrence 2003 Oxford University Press
10. N. Ram, and K.J. Grimm Growth mixture modeling: a method for identifying differences in longitudinal change among unobserved groups Int J Behav Dev 33 2009 565 576
11. B.J. Small, R.A. Dixon, J.J. McArdle, and K.J. Grimm Do changes in lifestyle engagement moderate cognitive decline in normal aging? Evidence from the Victoria Longitudinal Study Neuropsychology 26 2012 144 155
12. P.J. Curran, and A.M. Hussong Integrative data analysis: the simultaneous analysis of multiple data sets Psychol Methods 14 2009 81 100
13. J.J. McArdle, K.J. Grimm, F. Hamagami, R.P. Bowles, and W. Meredith Modeling life-span growth curves of cognition using longitudinal data with multiple samples and changing scales of measurement Psychol Methods 14 2009 126 149
14. B. Collins, J. Mackenzie, and C. Kyeremanteng Study of the cognitive effects of chemotherapy: considerations in selection of a control group J Clin Exp Neuropsychol 35 2013 435 444
15. S.Y. Guo, and M.W. Fraser Propensity score analysis: Statistical methods and applications 2009 Sage New York, NY
16. L.H. Heflin, B.E. Meyerowitz, P. Hall, and et al. Cancer as a risk factor for long-term cognitive deficits and dementia J Natl Cancer Inst 97 2005 854 856
17. T.H. Yamada, N.L. Denburg, L.J. Beglinger, and S.K. Schultz Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy J Neuropsychiatry Clin Neurosci 22 2010 48 54
18. M. Lange, B. Giffard, S. Noal, and et al. Baseline cognitive functions among elderly patients with localised breast cancer Eur J Cancer 50 2014 2181 2189
19. T.A. Ahles, A.J. Saykin, B.C. McDonald, and et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve J Clin Oncol 28 2010 4434 4440
20. A. Hurria, S. Goldfarb, C. Rosen, and et al. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective Breast Cancer Res Treat 98 2006 343 348
21. J.S. Mandelblatt, R.A. Stern, G. Luta, and et al. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol 32 2014 1909 1918
22. A. Hurria, K. Togawa, S.G. Mohile, and et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study J Clin Oncol 29 2011 3457 3465
23. B. Collins, J. Mackenzie, G.A. Tasca, C. Scherling, and A. Smith Cognitive effects of chemotherapy in breast cancer patients: a dose-response study Psychooncology 22 2013 1517 1527
24. H.K. Gan, L.J. Bernstein, J. Brown, and et al. Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 81 2011 126 134
25. F. Joly, S. Noal, N. Heutte, and et al. Impact of antiangiogenic treatment on cognitive functions and fatigue in metastatic renal cancer patients Eur J Cancer 49 2013 S598 S768
26. B. Buwalda, and S.B. Schagen Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment? Life Sci 93 2013 581 588
27. K.A. Phillips, J. Aldridge, K. Ribi, and et al. Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial Breast Cancer Res Treat 126 2011 221 226
28. K. Ribi, J. Aldridge, K.A. Phillips, and et al. Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer Br J Cancer 106 2012 1618 1625
29. C.M. Schilder, C. Seynaeve, L.V. Beex, and et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial J Clin Oncol 28 2010 1294 1300
30. A. Hurria, S.K. Patel, J. Mortimer, and et al. The effect of aromatase inhibition on the cognitive function of older patients with breast cancer Clin Breast Cancer 14 2014 132 140
31. R.J. Jamadar, M.J. Winters, and P.M. Maki Cognitive changes associated with ADT: a review of the literature Asian J Androl 14 2012 232 238
32. H.L. McGinty, K.M. Phillips, H.S. Jim, and et al. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis Support Care Cancer 22 2014 2271 2280
33. L.M. Wu, J. Austin, H. Valdimarsdottir, and et al. Cross-sectional study of patient-reported neurobehavioral problems following hematopoietic stem cell transplant and health-related quality of life Psychooncology 23 2014 1406 1414
34. K.M. Phillips, H.L. McGinty, J. Cessna, and et al. A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation Bone Marrow Transplant 48 2013 1350 1357
35. M. Lange, O. Rigal, B. Clarisse, and et al. Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists Cancer Treat Rev 40 2014 810 817
36. C.M. Bender, S.M. Sereika, C.M. Ryan, and et al. Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer? Menopause 20 2013 905 913
37. T.A. Ahles Brain vulnerability to chemotherapy toxicities Psychooncology 21 2012 1141 1148
38. J. Vardy, H.M. Dhillon, G.R. Pond, and et al. Cognitive function and fatigue after diagnosis of colorectal cancer Ann Oncol 25 2014 2404 2412
39. P.A. Ganz, J.E. Bower, L. Kwan, and et al. Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun 30 2013 S99 S108
40. J.D. Merriman, B.E. Aouizerat, D.J. Langford, and et al. Preliminary evidence of an association between an interleukin 6 promoter polymorphism and self-reported attentional function in oncology patients and their family caregivers Biol Res Nurs 16 2013 152 159
41. T.A. Ahles, A.J. Saykin, W.W. Noll, and et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy Psychooncology 12 2003 612 619
42. P.D. Cole, Y. Finkelstein, K.E. Stevenson, and et al. Polymorphisms in genes related to oxidative stress are associated with inferior cognitive function after therapy for childhood acute lymphoblastic leukemia J Clin Oncol 33 2015 2205 2211
43. T.A. Ahles, Y. Li, B.C. McDonald, and et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking Psychooncology 23 2014 1382 1390
44. S.B. Schagen, E. Das, and I. Vermeulen Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients Psychooncology 21 2012 1132 1135
45. B. Giffard, A. Viard, J. Dayan, and et al. Autobiographical memory, self, and stress-related psychiatric disorders: which implications in cancer patients? Neuropsychol Rev 23 2013 157 168
46. N. Morel, J. Dayan, P. Piolino, and et al. Specificities of autobiographical memory during period of breast cancer announcement Conscious Cogn 35 2015 42 52
47. L. Bergouignan, J.P. Lefranc, M. Chupin, and et al. Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval PLoS One 6 2011 e25349
48. A.J. Saykin, M.B. de Ruiter, B.C. McDonald, S. Deprez, and D.H. Silverman Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research Brain Imaging Behav 7 2013 363 373
49. R.J. Ferguson, B.C. McDonald, A.J. Saykin, and T.A. Ahles Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy J Clin Oncol 25 2007 3866 3870
50. B.C. McDonald, S.K. Conroy, D.J. Smith, J.D. West, and A.J. Saykin Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study Brain Behav Immun 30 2013 S117 S125
51. B.C. McDonald, S.K. Conroy, T.A. Ahles, J.D. West, and A.J. Saykin Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study Breast Cancer Res Treat 123 2010 819 828
52. B.C. McDonald, S.K. Conroy, T.A. Ahles, J.D. West, and A.J. Saykin Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study J Clin Oncol 30 2012 2500 2508
53. D.D. Correa, J.C. Root, R. Baser, and et al. A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients Brain Imaging Behav 7 2013 478 490
54. S. Deprez, F. Amant, A. Smeets, and et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning J Clin Oncol 30 2012 274 281
55. V. Koppelmans, M.D. Groot, M.B. de Ruiter, and et al. Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy Hum Brain Mapp 35 2012 889 899
56. S.K. Conroy, B.C. McDonald, D.J. Smith, and et al. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage Breast Cancer Res Treat 137 2013 493 502
57. J. Bruno, S.M. Hosseini, and S. Kesler Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors Neurobiol Dis 48 2012 329 338
58. K.L. Pomykala, P.A. Ganz, J.E. Bower, and et al. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer Brain Imaging Behav 7 2013 511 523
59. M. Dubois, N. Lapinte, V. Villier, and et al. Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant Neuropharmacology 79 2014 234 248
60. M. ElBeltagy, S. Mustafa, J. Umka, and et al. Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil Behav Brain Res 208 2010 112 117
61. M. ElBeltagy, S. Mustafa, J. Umka, and et al. The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus Brain Res Bull 88 2012 514 518
62. L.A. Christie, M.M. Acharya, V.K. Parihar, and et al. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy Clin Cancer Res 18 2012 1954 1965
63. J. Dietrich, K. Rao, S. Pastorino, and S. Kesari Corticosteroids in brain cancer patients: benefits and pitfalls Expert Rev Clin Pharmacol 4 2011 233 242
64. R. Seigers, M. Loos, T.O. van, W. Boogerd, A.B. Smit, and S.B. Schagen Cognitive impact of cytotoxic agents in mice Psychopharmacology (Berl) 232 2014 17 37
65. G. Winocur, J. Vardy, M.A. Binns, L. Kerr, and I. Tannock The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice Pharmacol Biochem Behav 85 2006 66 75
66. C.K. Tsang, H. Qi, L.F. Liu, and X.F. Zheng Targeting mammalian target of rapamycin (mTOR) for health and diseases Drug Discov Today 12 2007 112 124
67. M. Dubois, V. Le Joncour, M.C. Tonon, and et al. Evaluation of the impact of the cancer therapy everolimus on the central nervous system in mice PLoS One 9 2014 e113533
68. J.A. Broeckel, P.B. Jacobsen, L. Balducci, J. Horton, and G.H. Lyman Quality of life after adjuvant chemotherapy for breast cancer Breast Cancer Res Treat 62 2000 141 150
69. F.P. Downie, H.G. Mar Fan, N. Houede-Tchen, Q. Yi, and I.F. Tannock Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment Psychooncology 15 2006 921 930
70. A. Schuurs, and H.J. Green A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life Psychooncology 22 2013 1043 1049
71. M.M. Cherrier, K. Anderson, D. David, and et al. A randomized trial of cognitive rehabilitation in cancer survivors Life Sci 93 2013 617 622
72. L.M. Ercoli, S.A. Castellon, A.M. Hunter, and et al. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints Brain Imaging Behav 7 2013 543 553
73. S.B. Schagen, M. Klein, J.C. Reijneveld, and et al. Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions EJC Suppl 12 2014 29 40
74. K.D. Hodgson, A.D. Hutchinson, C.J. Wilson, and T. Nettelbeck A meta-analysis of the effects of chemotherapy on cognition in patients with cancer Cancer Treat Rev 39 2013 297 304
75. M.A. de Ruiter, M.R. van, A.Y. Schouten-van Meeteren, M.A. Grootenhuis, and J. Oosterlaan Neurocognitive consequences of a paediatric brain tumour and its treatment: a meta-analysis Dev Med Child Neurol 55 2013 408 417
76. P.K. Duffner, F.D. Armstrong, L. Chen, and et al. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group J Pediatr Hematol Oncol 36 2014 8 15
77. K.R. Krull, N.D. Sabin, W.E. Reddick, and et al. Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin lymphoma J Clin Oncol 30 2012 3618 3624
78. E.F. Smithson, R. Phillips, D.W. Harvey, and M.C. Morrall The use of stimulant medication to improve neurocognitive and learning outcomes in children diagnosed with brain tumours: a systematic review Eur J Cancer 49 2013 3029 3040
79. J.S. Wefel, D.J. Vidrine, S.K. Marani, and et al. A prospective study of cognitive function in men with non-seminomatous germ cell tumors Psychooncology 23 2014 626 633
80. J.A. Cruzado, S. Lopez-Santiago, V. Martinez-Marin, and et al. Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients Support Care Cancer 22 2014 1815 1823
81. T. Ng, Y.T. Cheung, Q.S. Ng, H.K. Ho, and A. Chan Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies Expert Opin Drug Saf 13 2014 83 92
82. S.F. Mulder, D. Bertens, I.M. Desar, and et al. Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study BMC Cancer 14 2014 219
83. R.J. Ferguson, B.C. McDonald, M.A. Rocque, and et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial Psychooncology 21 2012 176 186
84. S. Kesler, S.M. Hadi Hosseini, C. Heckler, and et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors Clin Breast Cancer 13 2013 299 306
85. B. Oh, P.N. Butow, B.A. Mullan, and et al. Effect of medical qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial Support Care Cancer 20 2012 1235 1242
86. K. Gehring, S.Y. Patwardhan, R. Collins, and et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor J Neurooncol 107 2012 165 174
87. G. Winocur, M. Henkelman, J.M. Wojtowicz, and et al. The effects of chemotherapy on cognitive function in a mouse model: a prospective study Clin Cancer Res 18 2012 3112 3121
88. M.J. Sharpe, J.E. Fardell, J. Vardy, and I.N. Johnston The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats Behav Brain Res 227 2012 295 299
89. K.B. Weymann, L.J. Wood, X. Zhu, and D.L. Marks A role for orexin in cytotoxic chemotherapy-induced fatigue Brain Behav Immun 37 2014 84 94
90. J.E. Fardell, J. Vardy, J.D. Shah, and I.N. Johnston Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity Psychopharmacology (Berl) 220 2012 183 193
91. M. Ji, L. Dong, M. Jia, and et al. Epigenetic enhancement of brain-derived neurotrophic factor signaling pathway improves cognitive impairments induced by isoflurane exposure in aged rats Mol Neurobiol 50 2014 937 944
92. P.D. Cole, V. Vijayanathan, N.F. Ali, and et al. Memantine protects rats treated with intrathecal methotrexate from developing spatial memory deficits Clin Cancer Res 19 2013 4446 4454
93. Y. Zou, R. Corniola, D. Leu, and et al. Extracellular superoxide dismutase is important for hippocampal neurogenesis and preservation of cognitive functions after irradiation Proc Natl Acad Sci U S A 109 2012 21522 21527
94. M. Yang, J. Kim, J.S. Kim, and et al. Hippocampal dysfunctions in tumor-bearing mice Brain Behav Immun 36 2014 147 155
95. S. Kesler, M. Janelsins, D. Koovakkattu, and et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors Brain Behav Immun 30 2013 S109 S116
96. M.G. Berman, M.K. Askren, M. Jung, and et al. Pretreatment worry and neurocognitive responses in women with breast cancer Health Psychol 33 2014 222 231
97. F. Versace, J.M. Engelmann, E.F. Jackson, and et al. Brain responses to erotic and other emotional stimuli in breast cancer survivors with and without distress about low sexual desire: a preliminary fMRI study Brain Imaging Behav 7 2013 533 542
98. H.H. Chao, E. Uchio, S. Zhang, and et al. Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis BMC Cancer 12 2012 371
99. J.A. Dumas, J. Makarewicz, G.J. Schaubhut, and et al. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study Brain Imaging Behav 7 2013 524 532
100. S.M. Hosseini, and S.R. Kesler Multivariate pattern analysis of fMRI in breast cancer survivors and healthy women J Int Neuropsychol Soc 20 2014 391 401
101. S.R. Kesler, J.S. Wefel, S.M. Hosseini, and et al. Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls Proc Natl Acad Sci U S A 110 2013 11600 11605
102. R.A. Lopez Zunini, C. Scherling, N. Wallis, and et al. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study Brain Imaging Behav 7 2013 460 477
103. F. D'Agata, T. Costa, P. Caroppo, and et al. Multivariate analysis of brain metabolism reveals chemotherapy effects on prefrontal cerebellar system when related to dorsal attention network EJNMMI Res 3 2013 22
104. A. Chiaravalloti, M. Pagani, P.B. Di, and et al. Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma? Nucl Med Commun 34 2013 57 63
105. B. Baudino, F. D'Agata, P. Caroppo, and et al. The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients Q J Nucl Med Mol Imaging 56 2012 559 568